S. 1302: Increasing Transparency in Generic Drug Applications Act
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2025-04-03 |
| Sponsor | Sen. Hassan, Margaret Wood [D-NH] |
| Policy area | Health |
| Cosponsors | 6 |
| Latest action | 2025-04-03 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| Last updated | 2026-02-05 |
Summary
An official summary for this measure has not been published by Congress. The full text is available on congress.gov.
Cosponsors (6)
| Name | Party / state |
|---|---|
| Rand Paul | R KY (original cosponsor) 2025-04-03 |
| John W. Hickenlooper | D CO (original cosponsor) 2025-04-03 |
| Mike Lee | R UT (original cosponsor) 2025-04-03 |
| James Lankford | R OK 2025-05-08 |
| Jon Ossoff | D GA 2025-12-09 |
| Jon Husted | R OH 2025-12-09 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 1302 are published by Congress on congress.gov.
View S. 1302 on congress.gov →
Frequently asked questions
What is S. 1302?
S. 1302 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Increasing Transparency in Generic Drug Applications Act.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 1302 are available on congress.gov.
Bill data: congress.gov API (official congressional records).